Market Overview:
The global anti-obesity medicine market is expected to grow at a CAGR of 7.5% from 2018 to 2030. The growth in the market can be attributed to the increasing prevalence of obesity, rising awareness about obesity and its associated health risks, and technological advancements in the field of anti-obesity drugs. The prescription drugs segment is expected to dominate the global anti-obesity medicine market during the forecast period owing to their high efficacy and safety as compared to over-the-counter (OTC) drugs. However, OTC drugs are anticipated to register higher growth rates during the forecast period due their easy availability and lower prices as compared to prescription drugs. Among applications, men are expected account for a larger share of the global anti-obesity medicine market than women during 2018–2030 owing higher prevalence rates of obesity among men as compared women globally. However, women are projected exhibit faster growth rates than men during the forecast period due increased awareness about obesity and its health risks among women across regions.
Product Definition:
Anti-obesity medicine is a type of medication that is used to help treat obesity. This type of medication can help to reduce the amount of fat that is stored in the body, as well as help to improve overall health and decrease the risk for developing certain diseases.
Prescription Drugs:
Prescription drugs are the ones that are given to a patient by a doctor after evaluating the need for its usage. Prescription drug includes therapeutic and prophylactic medicines.
OTC Drugs:
OTC drugs are the pharmaceutical products that are sold without a prescription. OTC drug market is expected to show significant growth over the forecast period owing to increasing demand for non-prescription medicines and growing awareness about self-medication among consumers. Obesity has become a major health concern across the globe in recent years, as it leads to numerous other chronic diseases such as diabetes, heart disease, stroke, and arthritis.
Application Insights:
Men application segment held the largest share of over 60.0% in 2017. The growing awareness about obesity and its related problems is boosting the usage of anti-obesity medicines in men population more than women population. In addition, there are few number of studies available for men compared to women regarding side effects and usage of these medicines which increases the adoption rate for weight loss treatment among male patients.
The increasing cases associated with lifestyle-related diseases such as cardiovascular diseases, type 2 diabetes mellitus etc., increase the demand for anti-obesity medicine especially among adult males population in developed countries including U.S., Canada, U.K., Germany etc.
Regional Analysis:
North America dominated the global market in 2017. The region is expected to maintain its position during the forecast period. This can be attributed to various factors such as high disposable income, availability of effective treatment methods, and rising awareness about obesity-related disorders among people of this region. Moreover, increasing cases of obesity have led healthcare providers to focus on developing new treatment options for obese patients thus driving regional growth.
Asia Pacific is anticipated to witness lucrative growth over the forecast period owing to rising prevalence rates of obesity coupled with growing health awareness levels amongst end users in countries such as China and India. In addition, improving economic conditions are also likely contribute towards rapid regional expansion during the same period due to increased spending capacity & demand for medicines among end users which will further boost industry development & adoption rate over next eight years to 2030 in terms of revenue generation from this region’s market share by 2030 in terms of value).
Growth Factors:
- Increasing obesity rates across the globe
- Growing awareness about the health risks associated with obesity
- Rising demand for weight loss treatments and products
- Availability of new and innovative anti-obesity drugs and therapies
- Growing number of obese people seeking medical help to lose weight
Scope Of The Report
Report Attributes
Report Details
Report Title
Anti-obesity Medicine Market Research Report
By Type
Prescription Drugs, OTC Drugs
By Application
Men, Women
By Companies
Alizyme, Amylin Pharmaceuticals, Arena Pharmaceuticals, Boehringer Ingelheim, Eisai, GlaxoSmithKline, Orexigen Therapeutics, Vivus, Pfizer, Roche, Merck, Novo Nordisk
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
156
Number of Tables & Figures
110
Customization Available
Yes, the report can be customized as per your need.
Global Anti-obesity Medicine Market Report Segments:
The global Anti-obesity Medicine market is segmented on the basis of:
Types
Prescription Drugs, OTC Drugs
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Men, Women
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Alizyme
- Amylin Pharmaceuticals
- Arena Pharmaceuticals
- Boehringer Ingelheim
- Eisai
- GlaxoSmithKline
- Orexigen Therapeutics
- Vivus
- Pfizer
- Roche
- Merck
- Novo Nordisk
Highlights of The Anti-obesity Medicine Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Prescription Drugs
- OTC Drugs
- By Application:
- Men
- Women
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Anti-obesity Medicine Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Anti-obesity medicine is a type of medication that helps people lose weight. It can be used in combination with other treatments, such as diet and exercise, to help people achieve their goals.
Some of the major players in the anti-obesity medicine market are Alizyme, Amylin Pharmaceuticals, Arena Pharmaceuticals, Boehringer Ingelheim, Eisai, GlaxoSmithKline, Orexigen Therapeutics, Vivus, Pfizer, Roche, Merck, Novo Nordisk.
The anti-obesity medicine market is expected to register a CAGR of 7.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Anti-obesity Medicine Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Anti-obesity Medicine Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Anti-obesity Medicine Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Anti-obesity Medicine Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Anti-obesity Medicine Market Size & Forecast, 2018-2028
4.5.1 Anti-obesity Medicine Market Size and Y-o-Y Growth
4.5.2 Anti-obesity Medicine Market Absolute $ Opportunity
Chapter 5 Global Anti-obesity Medicine Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Anti-obesity Medicine Market Size Forecast by Type
5.2.1 Prescription Drugs
5.2.2 OTC Drugs
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Anti-obesity Medicine Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Anti-obesity Medicine Market Size Forecast by Applications
6.2.1 Men
6.2.2 Women
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Anti-obesity Medicine Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Anti-obesity Medicine Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Anti-obesity Medicine Analysis and Forecast
9.1 Introduction
9.2 North America Anti-obesity Medicine Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Anti-obesity Medicine Market Size Forecast by Type
9.6.1 Prescription Drugs
9.6.2 OTC Drugs
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Anti-obesity Medicine Market Size Forecast by Applications
9.10.1 Men
9.10.2 Women
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Anti-obesity Medicine Analysis and Forecast
10.1 Introduction
10.2 Europe Anti-obesity Medicine Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Anti-obesity Medicine Market Size Forecast by Type
10.6.1 Prescription Drugs
10.6.2 OTC Drugs
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Anti-obesity Medicine Market Size Forecast by Applications
10.10.1 Men
10.10.2 Women
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Anti-obesity Medicine Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Anti-obesity Medicine Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Anti-obesity Medicine Market Size Forecast by Type
11.6.1 Prescription Drugs
11.6.2 OTC Drugs
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Anti-obesity Medicine Market Size Forecast by Applications
11.10.1 Men
11.10.2 Women
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Anti-obesity Medicine Analysis and Forecast
12.1 Introduction
12.2 Latin America Anti-obesity Medicine Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Anti-obesity Medicine Market Size Forecast by Type
12.6.1 Prescription Drugs
12.6.2 OTC Drugs
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Anti-obesity Medicine Market Size Forecast by Applications
12.10.1 Men
12.10.2 Women
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Anti-obesity Medicine Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Anti-obesity Medicine Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Anti-obesity Medicine Market Size Forecast by Type
13.6.1 Prescription Drugs
13.6.2 OTC Drugs
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Anti-obesity Medicine Market Size Forecast by Applications
13.10.1 Men
13.10.2 Women
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Anti-obesity Medicine Market: Competitive Dashboard
14.2 Global Anti-obesity Medicine Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Alizyme
14.3.2 Amylin Pharmaceuticals
14.3.3 Arena Pharmaceuticals
14.3.4 Boehringer Ingelheim
14.3.5 Eisai
14.3.6 GlaxoSmithKline
14.3.7 Orexigen Therapeutics
14.3.8 Vivus
14.3.9 Pfizer
14.3.10 Roche
14.3.11 Merck
14.3.12 Novo Nordisk
